NCT04347798View on ClinicalTrials.gov

IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT

CompletedOBSERVATIONAL
Enrollment

773

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Covid-19 InfectionRheumatoid ArthritisPsoriatic ArthritisHydroxychloroquine
Interventions
OTHER

Hydroxychloroquine/Chloroquine

Prospective evaluation of development of Covid-19 in inflammatory arthritis patients on biologics with anti-malarials compared to inflammatory arthritis patients on biologics without anti-malarial exposure

Trial Locations (1)

T6G 2G3

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT04347798 - IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT | Biotech Hunter | Biotech Hunter